Investing
Top Day Trader Alerts (ARST, BP, XIDE, MDNU, RPRX, SQNM, WEN)
Published:
Last Updated:
There are several big movers this morning for day traders and active traders that look for stocks with gap-ups or gap-downs. Stocks with news or events causing moves are ArcSight, Inc. (NASDAQ: ARST), BP plc (NYSE: BP), Exide Technologies (NASDAQ: XIDE), Medical Nutrition USA, Inc. (NASDAQ: MDNU), Repros Therapeutics Inc. (NASDAQ: RPRX), Sequenom Inc. (NASDAQ: SQNM), and Wendy’s/Arby’s Group, Inc. (NYSE: WEN). We have provided the color on each and the move on each with background data where applicable.
ArcSight, Inc. (NASDAQ: ARST) is one of the top gainers after beating earnings. Shares are up over 12% at $22.25 on almost 30,000 shares; the 52-week range is $14.23 to $29.33 and average volume is about 460,000 shares.
BP plc (NYSE: BP) is up again for a second day despite talks of a dividend cut. Shares are up 5.1% at $32.78 on almost 3 million shares. Shares closed at $32.78 after yesterday’s gap up and the intra-day range had a high of $33.04 and a low of $30.89.
Exide Technologies (NASDAQ: XIDE) is higher after announcing a new licensing agreement with Honeywell (NYSE: HON) consumer products unit to use the Autolite trademark on its batteries. Shares are up 5.5% at $5.69 on close to 25,000 shares.
Medical Nutrition USA, Inc. (NASDAQ: MDNU) is the top gainer at a 40% gain due to Danone acquiring the company. Danone North America, Inc. will acquire all the outstanding shares at $4.00 per share in cash, in a $62.3 million deal. Shares are up 40% at $3.91, but volume is tiny on this one.
Repros Therapeutics Inc. (NASDAQ: RPRX) is surging this morning on news that the FDA has lifted a full clinical hold to a partial hold on Repros Therapeutics’ Proellex. Shares are up almost 40% at $0.67 on about 75,000 shares. The 52-week range is $0.45 to $7.80 and average volume is 1.66 million shares.
Sequenom Inc. (NASDAQ: SQNM) is a large gainer after Auriga raised the rating to BUY from HOLD and raised the price target to $9.00. Shares are up 4.4% at $6.20 on about 75,000 shares.
Wendy’s/Arby’s Group, Inc. (NYSE: WEN) may be real or may be implied, but Nelson Peltz’s Trian Fund said in a SEC filing that it has received an oral inquiry from a third party that expressed preliminary interest about a possible acquisition involving Wendy’s/Arby’s Group. Shares are up 9.9% at $4.77 on over 50,000 shares; the 52-week range is $3.55 to $5.55. This was one of our recent “stocks which could double” in our screens.
You can join our free daily email distribution list to hear more about dividend trends, analyst upgrades and downgrades, top day trader and active trader alerts, news on Buffett and other investment gurus, IPOs, secondary offerings, private equity, and more.
JON C. OGG
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
